Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock

Critical Care Medicine

Volumn 29, Issue 11, 2001, Pages 2185-2193

  Oldner, A ^a   Konrad, D ^a   Weitzberg, E ^a   Rudehill, A ^a   Rossi, P ^a   Wanecek, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiac contractility; Endotoxemia; Levosimendan; Septic shock

Indexed keywords

CALCIUM; CALCIUM SENSITIZER; ENDOTHELIN 1; ENDOTOXIN; INOTROPIC AGENT; LEVOSIMENDAN; TROPONIN C;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPTIC SHOCK; SWINE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0035174034     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200111000-00022     Document Type: Article

References (36)

1. The effect of recombinant human activated protein C (RHAPC) on organ dysfunction and functional recovery in severe sepsis
2. Efficacy and safety of recombinant human activated protein C for severe sepsis
3. Reversible causes of severe myocardial dysfunction
4. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines
5. Myocardial dysfunction in sepsis: Clinical and experimental investigations
6. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits
7. Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes
8. Effects of dobutamine, norepinephrine and epinephrine on intramucosal pH and hemodynamics of dogs during endotoxic shock
9. Microcirculatory oxygenation and shunting in sepsis and shock
10. The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock
11. Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure
12. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells
13. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects
14. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction
15. i and contractility in isolated adult rabbit ventricular myocytes
16. Effects of MCI-154, a calcium sensitizer, on cardiac dysfunction in endotoxic shock in rabbits
17. The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog
18. Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig
19. Induction of the ATP-sensitive potassium (uK(ATP)-1) channel by endotoxemia
20. Molecular identification of 02 sensors and 02-sensitive potassium channels in the pulmonary circulation
21. Multiple-organ-failure syndrome
22. Splanchnic ischaemia/reperfusion and multiple organ failure
23. Gastric mucosal pH as a prognostic index of mortality in critically ill patients
24. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients
25. The Haldane effect - An alternative explanation for increasing gastric mucosal PCO2 gradients?
26. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs
27. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
28. The endothelin system in septic and endotoxin shock
29. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan
30. Differentiated effects on splanchnic homeostasis by selective and non- selective endothelin receptor antagonism in porcine endotoxaemia
31. Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: Relation to hemodynamic response
32. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs
33. Haemodynamic dose-efficacy of levosimendan in healthy volunteers
34. Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart
35. Lack of beneficial effects of milrinone in severe septic shock